Latest Regulatory News

AustChina Holdings has entered a binding agreement to acquire Penwortham Exploration, gaining access to promising gold-antimony and base metals projects in Tasmania’s prolific mining districts. The move positions AustChina to leverage modern exploration techniques on historically rich targets.

Wellnex Life has secured Therapeutic Goods Administration approval for its Liquid Paracetamol plus Caffeine Soft Gel, marking its fourth market authorisation and opening new revenue avenues.

Gold Hydrogen Limited has secured a $6.45 million R&D tax refund, strengthening its financial position ahead of an ambitious 2025 drilling campaign. The company also announced key leadership changes, including the appointment of a seasoned Chief Geologist.

Vonex Limited has announced a $13.9 million non-renounceable entitlement offer to reduce its substantial debt, with major shareholder Maxo Telecommunications underwriting the raise. The move comes as CEO Ian Porter prepares to depart, marking a pivotal moment for the telecommunications provider.

Viridis Mining and Minerals has raised A$3.5 million through a placement to fund critical development milestones for its Colossus Rare Earth Element project, following a major resource upgrade.

Emyria reports sustained and statistically significant improvements in PTSD symptoms and quality of life three months after MDMA-assisted therapy, signaling a potential breakthrough for treatment-resistant patients.

Rimfire Pacific Mining has confirmed the Currajong Prospect as a promising new high-grade scandium opportunity, supported by historic drill data. The company plans an extensive drilling campaign in early 2025 to further define this resource within its Fifield project portfolio.

Beamtree Holdings appoints Marek Stepniak as CEO, signaling a strategic push in international markets with a strong leadership hand familiar with the company’s growth trajectory.

Micro-X Limited has requested an immediate voluntary suspension of its shares on the ASX, pending a forthcoming equity raising announcement expected by February 10.

OncoSil Medical has secured authorization for 120 German hospitals to negotiate funding for its pancreatic cancer treatment device, marking a 43% increase from last year and signaling growing acceptance in Germany’s healthcare system.

Athena Resources has appointed Peter Jones as Managing Director and CEO, aiming to leverage his extensive Mid-West iron ore experience to advance the high-grade Byro Magnetite Project.

Noxopharm has successfully completed key in vitro safety tests for its SOF-SKN™ lupus drug, paving the way for the upcoming HERACLES Phase 1 clinical trial.